Manufacturing error clouds Oxford's Covid-19 vaccine study results
Published
Published
AstraZeneca PLC (LON:AZN) said it is mulling undertaking a new trial for the coronavirus (COVID-19) vaccine developed with Oxford..
“You’ve taken two studies for which different doses were used and come up with a composite that doesn’t represent either of..